ScienceDirect® Home Skip Main Navigation Links
You have guest access to ScienceDirect. Find out more.
 
Home
Browse
My Settings
Alerts
Help
 Quick Search
 Search tips (Opens new window)
    Clear all fields    
Life Sciences
Volume 76, Issue 12, 4 February 2005, Pages 1407-1426
 
Font Size: Decrease Font Size  Increase Font Size
 Abstract - selected
Article
Purchase PDF (495 K)

 
 
 
Related Articles in ScienceDirect
View More Related Articles
 
View Record in Scopus
 
doi:10.1016/j.lfs.2004.10.026    How to Cite or Link Using DOI (Opens New Window)
Copyright © 2004 Elsevier Inc. All rights reserved.

Anti-oxidant gene expression imbalance, aging and Down syndrome

Santosh SinhaCorresponding Author Contact Information, E-mail The Corresponding Author

Department of Biotechnology, Brain Insights, Inc., 17801 Sky Park Circle # K, Irvine, California-92614, USA

Received 9 June 2004; 
accepted 25 October 2004. 
Available online 22 December 2004.

Purchase the full-text article



References and further reading may be available for this article. To view references and further reading you must purchase this article.

Abstract

The expression of copper zinc superoxide dismutase (SOD1), manganese superoxide dismutase (SOD2), glutathione peroxidase (GPx), and catalase (CAT) genes have been detected in human skin fibroblast cells for 2 year normal child (control), 50 year old normal male and female and a 1 year old Down Syndrome (DS) male and female with established trisomy karyotype using the RT-PCR technique. Differential expression of these genes is quantified individually against a β-Actin gene that has been employed as an internal control. The immunoblotting of cell lysate proteins with polyclonal antibodies exhibit SOD1 (16 kD), SOD2 (40 kD), GPx (23 and 92 kD), CAT (64 kD), and Actin (43 kD) as translational products. The results demonstrate that the enhancement in the level of mRNAs encoding SOD1 in DS male and female, as well as aged male and female are 51, 21, 31 and 50% respectively compared to the normal child (control). In SOD2, DS male and female display higher (176%) and lower (26%) levels of expression whereas aged male and female exhibit enhanced levels of expression (66 and 119%) respectively compared to the control. This study demonstrates that DS affects the female less than the male whereas in the aging process, the female is more prone to oxidative damage than the male. These results not only indicate that the level of GPx mRNA is constant except in DS male, which shows a downward regulation but that even CAT mRNA is upward regulated in aged as well as in DS males and females. These disproportionate changes in anti-oxidant genes, which are incapable of coping with over expressed genes, may contribute towards the aging process, dementia and Down syndrome.

Keywords: Aging; Dementia; DS; Gene expression; Chromosome 21; SOD1; SOD2; GPx; CAT

Article Outline

Introduction
Materials and methods
Cell culture
RNA preparation
RNA purification and quantification
Synthesis of cDNA
RT-PCR
Gel electrophoresis
Quantification of RT-PCR products
Cell lysate protein
Polyacrylamide gel analysis
Silver staining
Protein transfer and Western blot
Statistical analysis
Results
Detection of brain specific transcripts in human skin fibroblast cultured cells
Levels of mRNAs of the anti-oxidant genes in aging
Levels of mRNAs of the anti-oxidant genes in DS
Marker of cellular growth rate and cell damage
Protein characterization
Discussion
Anti-oxidant genes and aging
Calcium buffering activity and intraneuronal fibrillary tangles
Neuritic plaques
Anti-oxidant genes and DS
Manifestation of dementia in DS
Conclusion
Acknowledgements
References




Life Sciences
Volume 76, Issue 12, 4 February 2005, Pages 1407-1426
 
Home
Browse
My Settings
Alerts
Help
Elsevier.com (Opens new window)
About ScienceDirect  |  Contact Us  |  Information for Advertisers  |  Terms & Conditions  |  Privacy Policy
Copyright © 2008 Elsevier B.V. All rights reserved. ScienceDirect® is a registered trademark of Elsevier B.V.